A Clinical Trial of Danhong Injection in Treating Acute Ischemic Stroke
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 320 participants.
Also called NCT02152280
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 320 participants
- Registry
-
NCT02152280
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT02152280. Randomized; double masking; primary purpose treatment. Start 2014-03 (registry gives no type); primary completion 2015-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Clinical Trial of Danhong Injection in Treating Acute Ischemic Stroke
- Condition
- Stroke
- Intervention (Drug)
- Danhong Injection
- Intervention (Drug)
- Normal Saline
- Lead sponsor
- Beijing Bozhiyin T&S Co., Ltd.
Record details
- Record id
cardio:ct-nct02152280- Content hash
bcebce811b7b4b6ee09a44a38b2d92f778d34545668a3c79f31d59c383271245